Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') today announced that ivonescimab, the Company's first-in-class PD-1/VEGF bispecific antibody, has achieved a statistically significant and clinically ...
The Falcons' four quarterbacks are essentially in two competitions: Who will be the starter and who will make the roster as QB3?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results